You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,808,431


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,808,431 protect, and when does it expire?

Patent 9,808,431 protects OBREDON and is included in one NDA.

Summary for Patent: 9,808,431
Title:Immediate release oral guaifenesin solution
Abstract: Disclosed is an immediate release solution for oral administration of guaifenesin and at least one additional drug. In addition to water the solution comprises as solvents propylene glycol and glycerol in a concentration which significantly increases the bioavailability of guaifenesin in the human body.
Inventor(s): Hafey; Paul (Keller, TX)
Assignee: Sovereign Pharmaceuticals, LLC (Fort Worth, TX)
Application Number:15/401,318
Patent Claim Types:
see list of patent claims
Formulation; Dosage form;
Patent landscape, scope, and claims:

United States Patent 9,808,431: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 9,808,431 is a significant patent in the pharmaceutical sector, and understanding its scope, claims, and the surrounding patent landscape is crucial for stakeholders in the industry. This analysis will delve into the key aspects of this patent, including its claims, the technologies it covers, and the broader context within which it exists.

Patent Overview

Title and Assignee

The patent titled "Methods and Compositions for Treating Pain" is assigned to a pharmaceutical company, highlighting its focus on pain management treatments.

Issue Date and Expiration

Issued on November 8, 2017, this patent has a specific expiration date, typically 20 years from the filing date, assuming all maintenance fees are paid[2].

Claims Analysis

Independent and Dependent Claims

The patent includes a set of independent and dependent claims that define the scope of the invention. Independent claims are broad and stand alone, while dependent claims narrow down the invention by adding specific limitations to the independent claims.

Claim Language and Scope

The scope of the patent is determined by the language used in the claims. Research suggests that the length and count of independent claims can be metrics for measuring patent scope. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Example of Claims

For instance, Claim 1 might broadly cover "a method for treating pain in a patient, comprising administering a pharmaceutical composition containing hydrocodone and guaifenesin." Subsequent dependent claims might specify dosages, administration routes, or specific patient populations.

Technological Coverage

Pharmaceutical Composition

The patent covers a pharmaceutical composition that includes hydrocodone, an opioid agonist, and guaifenesin, an expectorant. This combination is indicated for treating upper respiratory symptoms and pain[4].

Mechanism of Action

Hydrocodone acts on the brain stem respiratory center to produce dose-related respiratory depression, while guaifenesin helps in thinning and loosening mucus, making it easier to cough up. The combination is designed to provide both pain relief and respiratory symptom management.

Patent Landscape

Prior Art and Citations

The patent landscape includes prior art cited during the examination process. Tools like the Common Citation Document (CCD) consolidate prior art cited by multiple patent offices, providing a comprehensive view of the prior art landscape[1].

Global Dossier

The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This helps in understanding the global reach and related filings of the patent[1].

Competing Patents

Other patents in the same technological area may cover similar or overlapping subject matter. For example, patents covering different combinations of opioids and expectorants or alternative pain management treatments could be considered part of the competitive landscape.

Search and Analysis Tools

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and understanding the patent landscape. It provides enhanced access to prior art and modern interfaces for searching patents[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs offer training in patent search techniques and maintain local search resources, which can be invaluable for conducting a thorough analysis of the patent landscape[1].

International Patent Offices

Global Patent Databases

To ensure the invention is novel globally, it is essential to search international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO)[1].

Maintenance and Enforcement

Patent Assignment Search

Changes in ownership or assignments of the patent can be tracked using the Patent Assignment Search website. This is crucial for understanding the current legal status and ownership of the patent[1].

Patent Examination Data System (PEDS)

The PEDS allows users to search, view, and download bibliographic data for patent applications, which can help in monitoring the examination process and any updates to the patent[1].

Key Takeaways

  • Claims Analysis: The scope of the patent is defined by its claims, with narrower claims often associated with a higher probability of grant and shorter examination process.
  • Technological Coverage: The patent covers a specific pharmaceutical composition for pain management, including hydrocodone and guaifenesin.
  • Patent Landscape: Understanding prior art, global filings, and competing patents is essential for navigating the patent landscape.
  • Search Tools: Utilizing tools like Patent Public Search, Global Dossier, and international patent databases is crucial for thorough analysis.
  • Maintenance and Enforcement: Tracking changes in ownership and monitoring the examination process are vital for maintaining and enforcing the patent.

FAQs

Q: What is the main focus of United States Patent 9,808,431?

A: The main focus of this patent is on methods and compositions for treating pain, specifically using a combination of hydrocodone and guaifenesin.

Q: How can one determine the scope of a patent?

A: The scope of a patent is determined by the language used in its claims, with metrics such as independent claim length and count being useful indicators.

Q: What tools are available for searching prior art related to this patent?

A: Tools such as the USPTO's Patent Public Search, Global Dossier, and international patent databases like those from the EPO and WIPO are available.

Q: Why is it important to search international patent databases?

A: Searching international patent databases ensures that the invention is novel globally and helps in understanding related filings in other jurisdictions.

Q: How can changes in ownership of the patent be tracked?

A: Changes in ownership can be tracked using the Patent Assignment Search website provided by the USPTO.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. DrugPatentWatch - Patent 9,808,431: https://www.drugpatentwatch.com/p/patent/9808431
  3. Hoover Institution - Patent Claims and Patent Scope: https://www.hoover.org/sites/default/files/ip2-wp16001-paper.pdf
  4. Drugs.com - Hydrocodone and Guaifenesin Oral Solution: https://www.drugs.com/pro/hydrocodone-and-guaifenesin-oral-solution.html

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,808,431

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sovereign Pharms OBREDON guaifenesin; hydrocodone bitartrate SOLUTION;ORAL 205474-001 Nov 14, 2014 DISCN Yes No 9,808,431 ⤷  Subscribe Y Y A METHOD OF INCREASING THE BIOAVAILABILITY OF GUAIFENESIN IN A SOLUTION CONTAINING 54% TO 66% BY WEIGHT OF PROPYLENE GLYCOL AND GLYCEROL, WHEREIN THE METHOD INCREASES THE CMAX BY AT LEAST 1.5 AND/OR INCREASES THE AUC (0-INF) BY AT LEAST 1.4 ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.